Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 37 matching records.
37 results — page 1 of 2
- Level DLaboratory StudyEurope PMC
Comparing the growth kinetics and characteristics of Wharton's jelly derived mesenchymal stem cells expanded using different culture mediums
Laboratory Study on Immune Modulation, published in Cytotechnology (2025) — summary generated from the PubMed abstract.
- 2025
Cytotechnology2 citations - Level BClinical TrialEurope PMC
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Clinical Trial on Face & Skin, Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level DLaboratory StudyEurope PMC
Evaluation of the Interaction Between Wharton's Jelly-Derived Mesenchymal Stem Cells and β-Mercaptoethanol
Laboratory Study on Spinal Cord Injury, Neuroinflammation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus2 citations - Level DLaboratory StudyPubMed
Enhancing insulin sensitivity in type 2 diabetes mellitus using apelin-loaded small extracellular vesicles from Wharton's jelly-derived mesenchymal stem cells: a novel therapeutic approach.
Laboratory Study on Type 2 Diabetes, Chronic Inflammation, published in Diabetol Metab Syndr (2024) — summary generated from the PubMed abstract.
- 2024
Diabetol Metab Syndr - Level CProspective StudyPubMed
Exosomes Secreted by Wharton's Jelly-Derived Mesenchymal Stem Cells Promote the Ability of Cell Proliferation and Migration for Keratinocyte.
Prospective Study on Chronic Wound, Immune Modulation, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci - Level DLaboratory StudyPubMed
Expression Profile of New Marker Genes Involved in Differentiation of Human Wharton's Jelly-Derived Mesenchymal Stem Cells into Chondrocytes, Osteoblasts, Adipocytes and Neural-like Cells.
Laboratory Study on Immune Modulation, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci - Level DLaboratory StudyPubMed
Comparative Analysis of Porcine Adipose- and Wharton's Jelly-Derived Mesenchymal Stem Cells.
Laboratory Study, published in Animals (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Animals (Basel)7 citations - Level BClinical TrialEurope PMC
Feline Wharton's jelly-derived mesenchymal stem cells as a feeder layer for oocytes maturation and embryos culture in vitro
Clinical Trial, published in Front Vet Sci (2023) — summary generated from the PubMed abstract.
- 2023
Front Vet Sci1 citations - Level DAnimal StudyEurope PMC
Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment
Animal Study on Systemic / IV, published in J Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
J Transl Med5 citations - Level BClinical TrialEurope PMC
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Clinical Trial on Face & Skin, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther22 citations - Level BClinical TrialEurope PMC
Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts
Clinical Trial, published in Arch Toxicol (2022) — summary generated from the PubMed abstract.
- 2022
Arch Toxicol14 citations - Level DLaboratory StudyEurope PMC
Improvement of Corneal Nerve Regeneration in Diabetic Rats Using Wharton's Jelly-Derived Mesenchymal Stem Cells and their Conditioned Medium
Laboratory Study with a reported sample of 7, published in Int J Mol Cell Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 7
Int J Mol Cell Med1 citations - Level DLaboratory StudyEurope PMC
A Two-Stage Process for Differentiation of Wharton's Jelly-Derived Mesenchymal Stem Cells into Neuronal-like Cells
Laboratory Study on Neuroinflammation, published in Stem Cells Int (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cells Int4 citations - Level DLaboratory StudyEurope PMC
Neuroprotective effects of Wharton's jelly-derived mesenchymal stem cells on motor deficits due to Parkinson's disease
Laboratory Study on Neuroinflammation, published in Iran J Basic Med Sci (2021) — summary generated from the PubMed abstract.
- 2021
Iran J Basic Med Sci6 citations - Level BClinical TrialEurope PMC
Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results
Clinical Trial with a reported sample of 34 on Systemic / IV, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
- n = 34
Stem Cell Res Ther44 citations - Level DLaboratory StudyPubMed
Epigallocatechin-3-gallate protects Wharton's jelly derived mesenchymal stem cells against in vitro heat stress.
Laboratory Study on Burns, published in Eur J Pharmacol (2020) — summary generated from the PubMed abstract.
- 2020
Eur J Pharmacol8 citations - Level DAnimal StudyPubMed
Shockwave Therapy Combined with Autologous Adipose-Derived Mesenchymal Stem Cells Is Better than with Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells on Knee Osteoarthritis.
Animal Study on Knee Osteoarthritis, Osteoarthritis, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci21 citations - Level CProspective StudyEurope PMC
Xeno-Free Condition Enhances Therapeutic Functions of Human Wharton's Jelly-Derived Mesenchymal Stem Cells against Experimental Colitis by Upregulated Indoleamine 2,3-Dioxygenase Activity
Prospective Study on Chronic Inflammation, Immune Modulation, published in J Clin Med (2020) — summary generated from the PubMed abstract.
- 2020
J Clin Med21 citations - Level CProspective StudyPubMed
Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect.
Prospective Study, published in Am J Stem Cells (2020) — summary generated from the PubMed abstract.
- 2020
Am J Stem Cells - Level DLaboratory StudyEurope PMC
Circ6401, a novel circular RNA, is implicated in repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells through regulation of the miR-29b-1-5p/RAP1B axis
Laboratory Study, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cell Res Ther19 citations - Level CProspective StudyEurope PMC
Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
Prospective Study with a reported sample of 6 on Systemic / IV, published in Tuberc Respir Dis (Seoul) (2019) — summary generated from the PubMed abstract.
- 2019
- n = 6
Tuberc Respir Dis (Seoul)9 citations - Level DLaboratory StudyPubMed
Isolation, Expansion, and Characterization of Wharton's Jelly-Derived Mesenchymal Stromal Cell: Method to Identify Functional Passages for Experiments.
Laboratory Study, published in Methods Mol Biol (2019) — summary generated from the PubMed abstract.
- 2019
Methods Mol Biol - Level DAnimal StudyEurope PMC
Effects of Wharton's jelly-derived mesenchymal stem cells on chronic obstructive pulmonary disease
Animal Study on Face & Skin, published in Regen Ther (2019) — summary generated from the PubMed abstract.
- 2019
Regen Ther19 citations - Level BClinical TrialPubMed
Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
Clinical Trial on Back & Spine, Systemic / IV, published in Curr Res Transl Med (2019) — summary generated from the PubMed abstract.
- 2019
Curr Res Transl Med
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406